Search Results 271-280 of 16735 for alt
ALT/AST >= 3 x ULN; Bilirubin >= 3 mg/dL at Screening; Any known factor or disease that might interfere with treatment compliance, study conduct, or ...
... (ALT), and alkaline phosphatase (ALP), with the following exception: For participants with perinatal asphyxia, elevation of AST, ALT, or ALP 2mg/dL.
AST/ALT (SGOT/SGPT) < 2.5 x ULN for the reference laboratory or < 5 x ULN in the presence of liver metastases; Serum creatinine < 1.5 x ULN. No 'active' CNS ...
ALT: >40 IU/mL. Based on the judgment of the investigator, subject is not capable of complying with the study requirements. Participating Mayo Clinic ...
AST and ALT must be < 2.5 x ULN for the lab. Adequate renal function within 28 days before study entry defined as serum creatinine ≤ 1.5 x ULN for the lab ...
ALT > 1.5 × upper limit of normal (ULN). For subjects with a historical biopsy, is either not taking or is on stable doses of TZDs/glitazones or vitamin E ...
Serum AST and/or ALT > 3 times the upper limit of normal range'; Pregnancy (including family planning) or breastfeeding. Any circumstances or conditions ...
... (ALT), based on central laboratory results; Electromyography demonstrating active disease within the past 3 months; Active dermatomyositis (DM) skin rash ...
Liver function test (LFT) abnormalities: ALT and/or AST > 1.5 × ULN for age and gender. Known hypersensitivity to nedosiran, or any of its ingredients ...
Abnormal baseline liver function tests (ALT, AST, alkaline phosphatase, or bilirubin >upper limit of normal). Prolonged QTc interval on baseline ECG (>460 ms ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!